BBSRC Portfolio Analyser will be decommissioned at the end of 2025.
Other UKRI reporting services are available to you providing details of BBSRC investments: UKRI - What we have funded

Award details

Anti-inflammatory peptides based on chemokines

ReferenceBB/N003896/1
Principal Investigator / Supervisor Dr Jim Middleton
Co-Investigators /
Co-Supervisors
Institution University of Bristol
DepartmentOral and Dental Science
Funding typeResearch
Value (£) 7,987
StatusCompleted
TypeResearch Grant
Start date 29/05/2015
End date 28/02/2016
Duration9 months

Abstract

unavailable

Summary

unavailable
Committee Not funded via Committee
Research TopicsPharmaceuticals
Research PriorityX – Research Priority information not available
Research Initiative Follow-On Fund Pathfinder (FOF-Path) [2014-2015]
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file